PAR 4.08% 23.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-479

  1. 770 Posts.
    lightbulb Created with Sketch. 147
    Nothing too exciting in the broker data - small net volume for nearly all concerned except CBA Retail and maybe Nomura. It would have been nice to see a significant institution buying a few. A fairly significant spread of brokers in the list which means that there is a broad interest in the stock.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.